한국어
English
日本語
中文(简体)
Hyupjin Polyelga Jung (Porcine Spleen Hydrolyzed Powder)
OTC medication
HJ Hyupjin Co., Ltd.
MFDS drug class 03260
Long-acting formulations refer to a classification of drugs designed to have a gradual onset of action.
These drugs are designed to gradually release their effects over a certain period, providing continuous therapeutic benefits. They are used for chronic diseases or conditions that require long-term management.
Extended-release formulations are designed to release the drug slowly, maintaining a steady concentration in the blood. This allows the therapeutic effect to last longer, reducing the frequency of administration and stabilizing the treatment effect.
Extended-release formulations are categorized based on the rate of drug release and aim for sustained therapeutic effects, unlike regular formulations. Other classifications categorize drugs based on their mechanism of action or target conditions, but extended-release formulations are classified according to their release form.
Even within the same class, dosage form and prescription status can differ.
Drug classes are only attached to medicines covered by the MFDS pill identification data, so this list does not include every medicine.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.